The CCN2Ab showed a trend towards lowering the abundance of these collagens in the HFD + DM group (Fig. 3 C, D).
← all excerpts
Targeting CCN2 protects against progressive non-alcoholic steatohepatitis in a preclinical model induced by high-fat feeding and type 2 diabetes.
1
—
—